SEC Filings TLDR

The filing details the stock transactions of Peter J. Federico, an officer and director of AGNC Investment Corp. Federico plans to sell 45,798 shares of common stock on October 28, 2025, with an aggregate market value of $471,607.95. The shares were acquired through restricted stock vesting between July 2016 and Decemb...

Barry Goldman, an officer of Acuity Inc., has reported securities transactions involving the company's common stock. On October 25, 2024, Goldman acquired 2,839 shares through the vesting of stock awards. Another 1,650 shares were acquired on October 24, 2025, also through the vesting of stock awards. Additionally, Gol...

Jennifer Anne Smith, an officer of Zions Bancorporation, National Association, has filed a Form 144 to sell 2,458 shares of common stock. The shares were acquired through restricted stock vesting and dividend reinvestment. The sale is expected to occur on October 27, 2025, with an aggregate market value of $130,519.60....

The filing details the securities transactions of Carmen Amara, an officer of Yelp Inc. It includes the sale of 1,500 common shares on 09/25/2025 for $47,055.00 and another 1,500 common shares on 08/25/2025 for $48,495.00. Additionally, it mentions the acquisition of 1,500 common shares as restricted stock on 08/20/202...

MPM Asset Management Investors BV2014 LLC has filed a Form 144 with the SEC, indicating its intention to sell 4,479 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The notice was signed by Kristen Laguerre on October 27, 2025, and the plan was adopted o...

MPM BioVentures 2014 (B), L.P. has filed a notice indicating its intention to sell 8,679 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The sale is planned to occur on or around October 27, 2025, with Merrill Lynch acting as the broker. The aggregate m...

MPM Asset Management LLC has filed a notice to sell 20,597 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The sale is planned for October 27, 2025, with Merrill Lynch acting as the broker. The aggregate market value of the shares to be sold is $36,456....

UBS Oncology Impact Fund, L.P. has filed a Form 144 with the SEC indicating its intention to sell 107,463 common shares of Werewolf Therapeutics, Inc. These shares were acquired through a private placement on May 4, 2021. The sale is planned to occur around October 27, 2025, with Merrill Lynch acting as the broker. The...

MPM Oncology Innovations Fund, L.P. has filed a notice to sell 28,657 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The notice was signed by Kristen Laguerre on October 27, 2025, and the plan was adopted on September 24, 2025. The shares are to be sol...

MPM BioVentures 2014, L.P. has filed a Form 144 with the SEC indicating its intention to sell 130,125 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The planned sale is expected to occur around October 27, 2025, with an aggregate market value of approx...

On October 27, 2025, Michael Happe, an officer and director of Winnebago Industries, Inc., exercised stock options for 7,105 shares of common stock. The transaction was executed at a market value of approximately $294,005.61. The shares were acquired from the issuer, and the transaction was facilitated by Morgan Stanle...

James A. Burke, an officer and director of Vistra Corp., has reported significant transactions involving the company's common stock. On October 27, 2025, Burke acquired 20,473 shares through an option granted on April 9, 2018. Additionally, Burke has engaged in multiple sales of common stock over the past three months,...

Charles A. Rowland Jr., a director of Viking Therapeutics, Inc., has exercised options to acquire 60,000 shares of common stock under a registered plan. The transactions occurred on October 27, 2025, with the shares acquired at a payment date of the same day. The aggregate market value of the shares is approximately $2...

Robert Gendron, an officer at Vicor Corporation, has reported significant stock transactions. On October 27, 2025, Gendron exercised stock options to acquire 1,321 shares of common stock. Additionally, he sold 2,795 shares on October 24, 2025, for $252,948.62 and 2,116 shares on October 23, 2025, for $187,649.21. These...

Sean Crilly, an officer of Vicor Corporation, has filed a Form 144 notice indicating the intent to sell 12,000 shares of common stock. The shares were acquired on March 6, 2023, through the exercise of stock options. The approximate sale date is set for October 27, 2025, with an aggregate market value of $1,075,335.60....

Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp, has filed a Form 144 with the SEC. The filing details the sale of 4,000 common shares on October 27, 2025, with an aggregate market value of $1,662,173.20. The securities were acquired on March 15, 2016, through Execut...

Patrick Joseph Murphy, an officer of TransDigm Group Incorporated, has filed a Form 144 notice regarding the sale of securities. The filing indicates that Murphy plans to sell 580 shares of common stock acquired through the exercise of stock options on October 27, 2025. The aggregate market value of these shares is app...

The filing discloses that THE FORTUNA TRUST U/T/A DTD 06/01/2018, an officer of TransDigm Group Incorporated, plans to exercise stock options for 700 shares of common stock on 10/27/2025. The shares were acquired on the same date through the exercise of stock options. The aggregate market value of the shares is $951,51...

Margaret Tooth, an officer and director of Trupanion, Inc., has filed a Form 144 with the SEC detailing her planned sale of securities. The filing includes information on securities acquired through restricted stock and stock option exercises. Tooth acquired 1,442 shares of common stock on August 25, 2021, and May 25, ...

The filing details the securities transactions of Marc N. Casper, an officer and director of Thermo Fisher Scientific Inc. The notice, dated October 27, 2025, outlines the sale of 7,250 common shares acquired through an option granted on February 26, 2019. The aggregate market value of these shares is approximately $4,...

Ujjwal Kumar, a former officer of Teradyne, Inc., has filed a Form 144 to sell 2,861 shares of common stock. The shares were acquired through open market purchases and option grants. The total market value of the shares to be sold is approximately $429,150. The sale is scheduled to occur on October 27, 2025. The filing...

ZHANG KAIFU, an independent director of TAL Education Group, acquired 5,155 ADS (each representing one Class A common share) under the company's share incentive plan on October 27, 2025. The acquisition was based on the closing price of $12.60 on October 24, 2025, resulting in an aggregate market value of $64,953. The ...

PENG ALEX ZHUANGZHUANG, the President and CFO of TAL Education Group, acquired 15,294 ADS (each representing one Class A common share) under the company's share incentive plan on October 27, 2025. The acquisition was based on the closing price of $12.60 on October 24, 2025, resulting in an aggregate market value of $19...

The Hart Family Trust U/T/A DTD 10/24/2013 has filed a Form 144 with the SEC regarding the planned sale of 40,000 common shares of StepStone Group Inc. The shares were acquired on 12/02/2024 as Founders Shares. The notice date for this filing is 10/27/2025, and the plan adoption date is 11/21/2024. The aggregate market...

The filing details the stock transactions of Michael L. Richards, an officer at State Street Corp. It includes the vesting of restricted stock acquired on multiple dates: 776 shares on 02/15/2020, 494 shares on 05/15/2021, 14 shares on 02/25/2022, and 216 shares on 11/15/2022. Additionally, it reports the sale of 1,000...